OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Post-Induction High Adalimumab Drug Levels Predict Biological Remission at Week 24 in Patients With Crohn's Disease
Eran Zittan, A. Hillary Steinhart, Pavel Goldstein, et al.
Clinical and Translational Gastroenterology (2021) Vol. 12, Iss. 10, pp. e00401-e00401
Open Access | Times Cited: 7
Eran Zittan, A. Hillary Steinhart, Pavel Goldstein, et al.
Clinical and Translational Gastroenterology (2021) Vol. 12, Iss. 10, pp. e00401-e00401
Open Access | Times Cited: 7
Showing 7 citing articles:
Challenges in IBD Research 2024: Precision Medicine
Sana Syed, Brigid S. Boland, Lauren T Bourke, et al.
Inflammatory Bowel Diseases (2024) Vol. 30, Iss. Supplement_2, pp. S39-S54
Open Access | Times Cited: 9
Sana Syed, Brigid S. Boland, Lauren T Bourke, et al.
Inflammatory Bowel Diseases (2024) Vol. 30, Iss. Supplement_2, pp. S39-S54
Open Access | Times Cited: 9
Immunoassay methods used in clinical studies for the detection of anti-drug antibodies to adalimumab and infliximab
Boris Gorovits, Daniel Baltrukonis, Indranil Bhattacharya, et al.
Clinical & Experimental Immunology (2018) Vol. 192, Iss. 3, pp. 348-365
Open Access | Times Cited: 66
Boris Gorovits, Daniel Baltrukonis, Indranil Bhattacharya, et al.
Clinical & Experimental Immunology (2018) Vol. 192, Iss. 3, pp. 348-365
Open Access | Times Cited: 66
Precision medicine in inflammatory bowel disease: Individualizing the use of biologics and small molecule therapies
Eric Cheah, James Guoxian Huang
World Journal of Gastroenterology (2023) Vol. 29, Iss. 10, pp. 1539-1550
Open Access | Times Cited: 6
Eric Cheah, James Guoxian Huang
World Journal of Gastroenterology (2023) Vol. 29, Iss. 10, pp. 1539-1550
Open Access | Times Cited: 6
Infliximab vs adalimumab: Points to consider when selecting anti-tumor necrosis factor agents in pediatric patients with Crohn’s disease
Eun Sil Kim, Ben Kang
World Journal of Gastroenterology (2023) Vol. 29, Iss. 18, pp. 2784-2797
Open Access | Times Cited: 4
Eun Sil Kim, Ben Kang
World Journal of Gastroenterology (2023) Vol. 29, Iss. 18, pp. 2784-2797
Open Access | Times Cited: 4
Precision medicine in inflammatory bowel disease: Individualizing the use of biologics and small molecule therapies
Eric Cheah, James Guoxian Huang
World Journal of Gastroenterology (2023) Vol. 29, Iss. 10, pp. 1395-1406
Closed Access
Eric Cheah, James Guoxian Huang
World Journal of Gastroenterology (2023) Vol. 29, Iss. 10, pp. 1395-1406
Closed Access
Higher Adalimumab Trough Levels Are Associated with Histologic Remission and Mucosal Healing in Inflammatory Bowel Disease
Rochelle Wong, Lihui Qin, Yushan Pan, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 21, pp. 6796-6796
Open Access
Rochelle Wong, Lihui Qin, Yushan Pan, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 21, pp. 6796-6796
Open Access
Therapeutic Drug Monitoring in Practice for Inflammatory Bowel Disease
Bryant Megna, Byron P. Vaughn
Current Gastroenterology Reports (2022) Vol. 24, Iss. 12, pp. 191-200
Closed Access
Bryant Megna, Byron P. Vaughn
Current Gastroenterology Reports (2022) Vol. 24, Iss. 12, pp. 191-200
Closed Access
